Search results
Results from the WOW.Com Content Network
With several key data updates expected in 2025, the stock appears well-positioned for long-term growth, the analyst adds. ... and a price target of $172. BioNTech’s oncology pipeline was ...
This biotech stock looks like a bargain -- and not because its share price hovers around $42. Like BioNTech, Moderna achieved tremendous success with its COVID-19 vaccine.
COST data by YCharts. 3. Value stocks increase in popularity. Many stocks now trade at premium prices thanks to the huge gains of the last couple of years. Sooner or later, though, investors will ...
Price Action: BNTX shares are trading 9.5% higher at $201.1 in the premarket session on the last check Monday See more from BenzingaClick here for options trades from BenzingaEMA Safety Committee ...
Price Action: BNTX stock is up 5.87% at $112.57 at the last check on Wednesday. Read Next: Regeneron/Sanofi’s Dupixent Approval Signals Major Treatment Breakthrough For Smokers’ Lung Disease
Shares of coronavirus disease vaccine maker Pfizer and its partner BioNTech could rise on Monday following a New York Times report that the U.S. Food and Drug Administration (FDA) is aiming to ...
Monday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss of 97 cents. The COVID-19 vaccine ...
For premium support please call: 800-290-4726 more ways to reach us